2019 | Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater | CANCER IMMUNOLOGY IMMUNOTHERAPY |
2018 | TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade
| EXPERIMENTAL AND MOLECULAR MEDICINE |
2018 | Multiple systemic extraneural metastasis of glioblastoma | CHIRURGIA |
2018 | Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer | AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE |
2017 | Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
| CANCER RESEARCH AND TREATMENT |
2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| MEDICINE |
2017 | Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
| YONSEI MEDICAL JOURNAL |
2017 | Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
| ONCOTARGET |
2016 | Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study
| MEDICINE |
2016 | Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells | APOPTOSIS |
2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | JOURNAL OF NEURO-ONCOLOGY |
2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| CANCER RESEARCH AND TREATMENT |
2015 | Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2015 | Prediction of short- and long-term survival for advanced cancer patients after ICU admission | SUPPORTIVE CARE IN CANCER |
2015 | Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer | TRANSLATIONAL ONCOLOGY |
2015 | Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report.
| YONSEI MEDICAL JOURNAL |
2015 | Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2015 | Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells | CELLULAR SIGNALLING |
2015 | ¹⁸F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis | NUCLEAR MEDICINE COMMUNICATIONS |
2014 | A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma. | CLINICAL CANCER RESEARCH |
2014 | Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma. | JOURNAL OF NEURO-ONCOLOGY |
2014 | Prognostic Significance of Volume-Based FDG PET/CT Parameters in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation Therapy
| YONSEI MEDICAL JOURNAL |
2014 | Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer | JOURNAL OF NUCLEAR MEDICINE |
2013 | Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer | BREAST |
2013 | Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma
| CANCER RESEARCH AND TREATMENT |
2013 | Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater
| TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE |
2013 | Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer
| YONSEI MEDICAL JOURNAL |
2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| SUPPORTIVE CARE IN CANCER |
2012 | 동영상 운동프로그램이 항암 화학요법을 받는 암환자의 피로와 신체기능 및 정서상태에 미치는 효과
| Journal of Korean Clinical Nursing Research (임상간호연구) |
2012 | In vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) in solid pseudopapillary tumor of the pancreas | PANCREAS |
2012 | Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study | LANCET ONCOLOGY |
2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
2012 | Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study | INVESTIGATIONAL NEW DRUGS |
2011 | 항암화학요법을 받는 환자의 구강관리 프로토콜개발 및 적용효과
| Journal of Korean Clinical Nursing Research (임상간호연구) |
2011 | 전이성 간암의 치료
| Korean Journal of Medicine |
2011 | 진행성 간암에서 전신 요법 | Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
2011 | Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib | LIVER INTERNATIONAL |
2011 | Serous Cystic Neoplasm: Do We Have to Wait Till It Causes Trouble?.
| Korean Journal of Hepato-Biliary-Pancreatic Surgery |
2011 | Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using 18F-FDG PET/CTand 99mTc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation.
| NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2011 | Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | LUNG CANCER |
2011 | MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation
| ONCOLOGY REPORTS |
2010 | Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients | ONCOLOGY |
2010 | Outcome of adjuvant therapy for gallbladder cancer | ONCOLOGY |
2010 | Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial | LUNG CANCER |
2010 | Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
2010 | Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer.
| CANCER |
2010 | Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2009 | Complete response of recurrent squamous cell carcinoma of the lung: dose the dose matter? | JOURNAL OF THORACIC ONCOLOGY |